Hadasit Bio (HDST) - Cash Flow Conversion Efficiency

Latest as of June 2022: -0.009x

Based on the latest financial reports, Hadasit Bio (HDST) has a cash flow conversion efficiency ratio of -0.009x as of June 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-360.50K ≈ $-966.49 USD) by net assets (ILA39.81 Million ≈ $106.73K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Hadasit Bio for the company's overall valuation and market capitalisation.

Hadasit Bio - Cash Flow Conversion Efficiency Trend (2013–2022)

This chart illustrates how Hadasit Bio's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hadasit Bio Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hadasit Bio ranked by their cash flow conversion efficiency. Explore cash flow quality index of Hadasit Bio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
France Tourisme Immobilier SA PA:MLFTI	N/A
Camellia Plc LSE:CAM	-0.059x
Thai Polycons Public Company Limited BK:TPOLY	0.129x
Spectra Inc. V:SSA	-0.026x
Northern Venture Trust LSE:NVT	-0.025x
QUHUO LTD SP.ADR/10 CL.A F:9J40	N/A
RareX Limited F:CK1	-0.102x
Crest Nicholson Holdings plc LSE:CRST	-0.142x

Annual Cash Flow Conversion Efficiency for Hadasit Bio (2013–2022)

The table below shows the annual cash flow conversion efficiency of Hadasit Bio from 2013 to 2022. View latest Hadasit Bio stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2022-12-31	ILA35.08 Million ≈ $94.04K	ILA-2.12 Million ≈ $-5.67K	-0.060x	-88.52%
2021-12-31	ILA65.69 Million ≈ $176.12K	ILA-2.10 Million ≈ $-5.63K	-0.032x	+70.05%
2020-12-31	ILA37.11 Million ≈ $99.49K	ILA-3.96 Million ≈ $-10.62K	-0.107x	+81.53%
2019-12-31	ILA5.50 Million ≈ $14.75K	ILA-3.18 Million ≈ $-8.53K	-0.578x	-20.50%
2018-12-31	ILA34.30 Million ≈ $91.96K	ILA-16.46 Million ≈ $-44.12K	-0.480x	-65.93%
2017-12-31	ILA60.79 Million ≈ $162.97K	ILA-17.57 Million ≈ $-47.12K	-0.289x	-21.36%
2016-12-31	ILA61.62 Million ≈ $165.20K	ILA-14.68 Million ≈ $-39.36K	-0.238x	-8.35%
2015-12-31	ILA60.30 Million ≈ $161.66K	ILA-13.26 Million ≈ $-35.55K	-0.220x	+60.29%
2014-12-31	ILA22.11 Million ≈ $59.28K	ILA-12.24 Million ≈ $-32.82K	-0.554x	-18.68%
2013-12-31	ILA24.89 Million ≈ $66.72K	ILA-11.61 Million ≈ $-31.13K	-0.467x	--

About Hadasit Bio

TA:HDST Israel Biotechnology & Medical Research

Market Cap

$1.78 Million

ILA665.31 Million ILA

Market Cap Rank

#30221 Global

#441 in Israel

Share Price

ILA60.00

Change (1 day)

+9.09%

52-Week Range

ILA30.00 - ILA83.00

All Time High

ILA2847.77